Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | LA |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | LA |
As of 10May2025 I contracted Covid-19 based on the Lucira test taken; As of 10May2025 I contracted Covid-19 based on the Lucira test taken; This is a spontaneous report received from a Consumer or other non HCP. An adult female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 02Oct2024 at 10:15 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 02Oct2024 as dose number unknown, single), in left arm for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09May2025 at 14:00, outcome "not recovered" and all described as "As of 10May2025 I contracted Covid-19 based on the Lucira test taken". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10May2025) contracted Covid-19. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Clinical course: The reporter informed that the vaccine location was at the upper left arm and the facility type was workplace clinic. The patient has no other vaccine in four weeks and has no other medications in two weeks. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Test Date: 20250510; Test Name: Lucira test; Result Unstructured Data: Test Result:contracted Covid-19